IBDEI12I ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17347,0)
 ;;=F18.10^^61^787^99
 ;;^UTILITY(U,$J,358.3,17347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17347,1,3,0)
 ;;=3^Inhalant Abuse,Uncomplicated
 ;;^UTILITY(U,$J,358.3,17347,1,4,0)
 ;;=4^F18.10
 ;;^UTILITY(U,$J,358.3,17347,2)
 ;;=^5003380
 ;;^UTILITY(U,$J,358.3,17348,0)
 ;;=F55.0^^61^787^41
 ;;^UTILITY(U,$J,358.3,17348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17348,1,3,0)
 ;;=3^Antacid Abuse
 ;;^UTILITY(U,$J,358.3,17348,1,4,0)
 ;;=4^F55.0
 ;;^UTILITY(U,$J,358.3,17348,2)
 ;;=^5003628
 ;;^UTILITY(U,$J,358.3,17349,0)
 ;;=F18.90^^61^787^100
 ;;^UTILITY(U,$J,358.3,17349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17349,1,3,0)
 ;;=3^Inhalant Use Uncomplicated,Unspec
 ;;^UTILITY(U,$J,358.3,17349,1,4,0)
 ;;=4^F18.90
 ;;^UTILITY(U,$J,358.3,17349,2)
 ;;=^5003405
 ;;^UTILITY(U,$J,358.3,17350,0)
 ;;=F55.2^^61^787^106
 ;;^UTILITY(U,$J,358.3,17350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17350,1,3,0)
 ;;=3^Laxative Abuse
 ;;^UTILITY(U,$J,358.3,17350,1,4,0)
 ;;=4^F55.2
 ;;^UTILITY(U,$J,358.3,17350,2)
 ;;=^5003630
 ;;^UTILITY(U,$J,358.3,17351,0)
 ;;=F55.1^^61^787^85
 ;;^UTILITY(U,$J,358.3,17351,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17351,1,3,0)
 ;;=3^Herbal/Folk Remedy Abuse
 ;;^UTILITY(U,$J,358.3,17351,1,4,0)
 ;;=4^F55.1
 ;;^UTILITY(U,$J,358.3,17351,2)
 ;;=^5003629
 ;;^UTILITY(U,$J,358.3,17352,0)
 ;;=F55.8^^61^787^128
 ;;^UTILITY(U,$J,358.3,17352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17352,1,3,0)
 ;;=3^Non-Psychoactive Substance Abuse
 ;;^UTILITY(U,$J,358.3,17352,1,4,0)
 ;;=4^F55.8
 ;;^UTILITY(U,$J,358.3,17352,2)
 ;;=^5003633
 ;;^UTILITY(U,$J,358.3,17353,0)
 ;;=F55.4^^61^787^167
 ;;^UTILITY(U,$J,358.3,17353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17353,1,3,0)
 ;;=3^Vitamin Abuse
 ;;^UTILITY(U,$J,358.3,17353,1,4,0)
 ;;=4^F55.4
 ;;^UTILITY(U,$J,358.3,17353,2)
 ;;=^5003632
 ;;^UTILITY(U,$J,358.3,17354,0)
 ;;=F55.3^^61^787^157
 ;;^UTILITY(U,$J,358.3,17354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17354,1,3,0)
 ;;=3^Steroid/Hormone Abuse
 ;;^UTILITY(U,$J,358.3,17354,1,4,0)
 ;;=4^F55.3
 ;;^UTILITY(U,$J,358.3,17354,2)
 ;;=^5003631
 ;;^UTILITY(U,$J,358.3,17355,0)
 ;;=F51.09^^61^787^101
 ;;^UTILITY(U,$J,358.3,17355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17355,1,3,0)
 ;;=3^Insomnia not d/t Substance/Known Physiol Condition
 ;;^UTILITY(U,$J,358.3,17355,1,4,0)
 ;;=4^F51.09
 ;;^UTILITY(U,$J,358.3,17355,2)
 ;;=^5003608
 ;;^UTILITY(U,$J,358.3,17356,0)
 ;;=H53.9^^61^787^165
 ;;^UTILITY(U,$J,358.3,17356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17356,1,3,0)
 ;;=3^Visual Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,17356,1,4,0)
 ;;=4^H53.9
 ;;^UTILITY(U,$J,358.3,17356,2)
 ;;=^124001
 ;;^UTILITY(U,$J,358.3,17357,0)
 ;;=I89.0^^61^787^117
 ;;^UTILITY(U,$J,358.3,17357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17357,1,3,0)
 ;;=3^Lymphedema NEC
 ;;^UTILITY(U,$J,358.3,17357,1,4,0)
 ;;=4^I89.0
 ;;^UTILITY(U,$J,358.3,17357,2)
 ;;=^5008073
 ;;^UTILITY(U,$J,358.3,17358,0)
 ;;=I87.1^^61^787^164
 ;;^UTILITY(U,$J,358.3,17358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17358,1,3,0)
 ;;=3^Vein Compression
 ;;^UTILITY(U,$J,358.3,17358,1,4,0)
 ;;=4^I87.1
 ;;^UTILITY(U,$J,358.3,17358,2)
 ;;=^269850
 ;;^UTILITY(U,$J,358.3,17359,0)
 ;;=N39.3^^61^787^158
 ;;^UTILITY(U,$J,358.3,17359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17359,1,3,0)
 ;;=3^Stress Incontinence (Female/Male)
